専門分野

臨床疫学、医療経済学、腎臓リハビリテーション

人材育成

専門課程
1 地域保健臨床研修専攻科　　

短期研修
1 保健医療事業の経済的評価に関する研修　　副主任

研究実績

原著論文

1 Suzuki Y, Hoshi K, Shiroiwa T, Fukuda T. Cost-effectiveness analysis of lifestyle interventions for preventing kidney disease in patients with type 2 diabetes. Clin Exp Nephrol. 2023 May 17.

2 Suzuki Y, Kaneko H, Yano Y, Okada A, Hashimoto Y, Itoh H, Matsuoka S, Yokota I, Fujiu K, Michihata N, Jo T, Takeda N, Morita H, Kamiya K, Matsunaga A, Ako J, Node K, Yasunaga H, Komuro I. Threshold of BMI for the Development of Hypertension among Japanese Adults. J Nutr. 2022 Nov;152(11):2565-2571.

3 Suzuki Y, Kaneko H, Yano Y, Okada A, Itoh H, Matsuoka S, Yokota I, Imaizumi T, Fujiu K, Michihata N, Jo T, Takeda N, Morita H, Node K, Yasunaga H, Komuro I. Interaction of Blood Pressure and Glycemic Status in Developing Cardiovascular Disease: Analysis of a Nationwide Real-World Database. J Am Heart Assoc. 2023 Jan 3;12(1):e026192.

4 Suzuki Y, Kaneko H, Yano Y, Okada A, Matsuoka S, Fujiu K, Michihata N, Jo T, Takeda N, Morita H, Node K, Yasunaga H, Komuro I. Reduction in blood pressure for people with isolated diastolic hypertension and cardiovascular outcomes. Eur J Prev Cardiol. 2023 Aug 1;30(10):928-934.

5 Suzuki Y, Kaneko H, Yano Y, Okada A, Itoh H, Ueno K, Matsuoka S, Fujiu K, Michihata N, Jo T, Takeda N, Morita H, Yokota I, Node K, Yasunaga H, Komuro I. Dose-dependent relationship of blood pressure and glycaemic status with risk of aortic dissection and aneurysm. Eur J Prev Cardiol. 2022 Dec 21;29(18):2338-2346.

6 Suzuki Y, Harada M, Matsuzawa R, Hoshi K, Koh YM, Aoyama N, Uemura K, Yamamoto S, Imamura K, Yoshikoshi S, Kamiya K, Yoshida A, Shoji T, Matsunaga A. Trajectory of Serum Albumin Prior to Death in Patients Receiving Hemodialysis. J Ren Nutr. 2023 Mar;33(2):368-375.

7 Suzuki Y, Kaneko H, Okada A, Matsuoka S, Fujiu K, Michihata N, Jo T, Takeda N, Morita H, Node K, Nangaku M, Yasunaga H, Komuro I. Kidney outcomes in patients with diabetes mellitus did not differ between individual sodium-glucose cotransporter-2 inhibitors. Kidney Int. 2022 Nov;102(5):1147-1153.

8 Suzuki Y, Kaneko H, Okada A, Itoh H, Matsuoka S, Fujiu K, Michihata N, Jo T, Takeda N, Morita H, Kamiya K, Matsunaga A, Ako J, Node K, Yasunaga H, Komuro I. Comparison of cardiovascular outcomes between SGLT2 inhibitors in diabetes mellitus. Cardiovasc Diabetol. 2022 May 18;21(1):67.

9 Suzuki Y, Kaneko H, Okada A, Matsuoka S, Itoh H, Fujiu K, Michihata N, Jo T, Takeda N, Morita H, Yamaguchi S, Node K, Yamauchi T, Yasunaga H, Komuro I. Prediabetes in Young Adults and Its Association With Cardiovascular Health Metrics in the Progression to Diabetes. J Clin Endocrinol Metab. 2022 Jun 16;107(7):1843-1853.

10 Suzuki Y, Matsuzawa R, Kamiya K, Hoshi K, Harada M, Watanabe T, Shimoda T, Yamamoto S, Matsunaga Y, Yoshida A, Matsunaga A. Trajectory of Lean Body Mass Assessed Using the Modified Creatinine Index and Mortality in Hemodialysis Patients. Am J Kidney Dis. 2020 Feb;75(2):195-203.